Literature DB >> 24746840

Interleukin-1α neutralisation in patients with cancer.

Charles Anthony Dinarello1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24746840     DOI： 10.1016/S1470-2045(14)70164-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  14 in total

Review 1.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

2.  Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer.

Authors:  David S Hong; Filip Janku; Aung Naing; Gerald S Falchook; Sarina Piha-Paul; Jennifer J Wheler; Siqing Fu; Apostolia M Tsimberidou; Michael Stecher; Prasant Mohanty; John Simard; Razelle Kurzrock
Journal:  Invest New Drugs       Date:  2015-03-31       Impact factor: 3.850

3.  PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer.

Authors:  Marianne R Spalinger; Roberto Manzini; Larissa Hering; Julianne B Riggs; Claudia Gottier; Silvia Lang; Kirstin Atrott; Antonia Fettelschoss; Florian Olomski; Thomas M Kündig; Michael Fried; Declan F McCole; Gerhard Rogler; Michael Scharl
Journal:  Cell Rep       Date:  2018-02-13       Impact factor: 9.423

Review 4.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

Review 5.  IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.

Authors:  Dov B Ballak; Rinke Stienstra; Cees J Tack; Charles A Dinarello; Janna A van Diepen
Journal:  Cytokine       Date:  2015-07-17       Impact factor: 3.861

6.  Pharmacological inhibition of caspase-8 limits lung tumour outgrowth.

Authors:  Michela Terlizzi; Vincenzo Giuseppe Di Crescenzo; Giuseppe Perillo; Antonio Galderisi; Aldo Pinto; Rosalinda Sorrentino
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

7.  Cell autonomous or systemic EGFR blockade alters the immune-environment in squamous cell carcinomas.

Authors:  Francesca Mascia; Derek T Schloemann; Christophe Cataisson; Katherine M McKinnon; Ludmila Krymskaya; Karen M Wolcott; Stuart H Yuspa
Journal:  Int J Cancer       Date:  2016-08-29       Impact factor: 7.396

Review 8.  Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.

Authors:  Jawed A Siddiqui; Ramesh Pothuraju; Maneesh Jain; Surinder K Batra; Mohd W Nasser
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-03-25       Impact factor: 10.680

Review 9.  Function and regulation of IL-1α in inflammatory diseases and cancer.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 10.  Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.

Authors:  Peleg Rider; Yaron Carmi; Idan Cohen
Journal:  Int J Cell Biol       Date:  2016-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.